medigraphic.com

2004, Number 5

<< Back Next >>

Cir Cir 2004; 72 (5)

Peripheral hereditary neuropathies: Charcot-Marie-Tooth types 1 and 2

Villegas-Castrejón H, Solís-Arrieta L, Martínez-Flores F , Escobar-Cedillo RE, García-Pérez BE

Language: Spanish
References: 29
Page: 387-394
PDF size: 193.57 Kb.


ABSTRACT

Objective: We report 14 cases of patients with Charcot-Marie-Tooth types 1 (CMT) and type 2 (CMT2). The objective of this study was to determine the diagnostic value of structural studies of peripheral nerve and striated muscle biopsies and to discuss correlations with clinical symptoms and electrophysiologic findings. Material and methods: Nerve and muscle biopsies were obtained and processed according to standards methods for transmission electron microscopy. Diagnosis of CMT was based on clinical electrophysiologic findings. Results: Our results demonstrated that myelinated fibers showed moderate-to- severe demyelinization and remyelinization, folding complex, tomacula formations, and presence of moderate vacuoles into myelin. The axonal cytoskeleton shows an important decrease of neurofilaments and microtubules in myelinated and unmyelinated nerves. Striated muscle showed different degenerative changes in Z disc. One important finding was presence of crystals inclusions in mitochondrion. In 11 cases, it was possible to find relevant changes in mitochondria-like hyperplasia. In this study, we had four cases with > 20 years of evolution; these cases showed relevant degenerative changes in nerve and muscle. Nerves presented great demyelination with damage in cytoskeleton of the axon, while fibers of muscle had necrosis and hyalinization. Conclusions: According to our results, it is possible to distinguish morphologically CMT subtypes, due to the fact that in CMT2 we found a 50% decrease of filaments and microtubules that were reduced in myelinic axons; this finding does not occur in CMT1.


REFERENCES

  1. Charcot JM, Marie P. Sur une forme particulière d’atrophie musculaire progressive souvent familiale débutant par le pies et les jambes et atteigmant plus tard les mains. Rev Med 1886;6:97-138.

  2. Tooth HH. The peroneal type of progresive muscular atrophy. London: H.K. Lewis and Co;1886.

  3. Hoffmann J. Ueber progressive neurotische muskelatrophie. Arch Psychiatr Nervenkr 1889;20:660-713.

  4. Thomas PK, Calne DB. Motor nerve conduction velocity in peroneal muscular atrophy: evidence for genetic heterogeneity. J Neurol Neurosurg Psychiatry 1974;37:68-74.

  5. Berciano J, Combarros O. Hereditary neuropathies. Curr Opin Neurol 2003;16:613-622.

  6. Combarros O, Calleja J, Polo JM, Berciano J. Prevalence of hereditary motor and sensory neuropathy in Cantabria. Acta Neurol Scand 1987;7:9-12.

  7. Lupski JR, Wise CA, Kuwano A, et al. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type IA. Nat Genet 1992;1:29-33.

  8. Naef R, Sutter U. Many facts of the peripheral myelin protein PMP-22 in myelination and disease. Microsc Res Tech 1998;1:359-371.

  9. Aarskog NK, Vedelar CA. Real time quantitative polymerase chain reaction: a new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in heredity neuropathy with liability to pressure palsies. Hum Genet 2000;107:494-498.

  10. Boerkoel CF, Takashima H, Garcñia CA, et al. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype phenotype correlation. Ann Neurol 2002;51:190-201.

  11. Hattori N, Yamoto M, Yoshihara T, et al. Demyelination and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP-22, MPZ and X32): a clinic pathological study of 205 Japanese patients. Brain 2003;126:134-151.

  12. Ionasescu VV, Ionasescu R, Searby C. Correlation between connexin 32 gene mutations and clinical phenotype in X-linked dominant Charcot-Marie-Tooth neuropathy. Am J Med Genet 1996;63:486-491.

  13. Raeymaekers P, Timmerman V, Nelis E, et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1A (CMT1A). The HMSN Collaborative Research Group. Neuromusc Disord 1991;1:93-97.

  14. Hanemann CO, Stoll G, D’Urso D, et al. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies. J Neurosci Res 1994;34:654-659.

  15. Taylor V, Welcher AA, Program AE, Sutter U. Epithelial membrane protein I, peripheral myelin protein-22, and lens membrane protein 20 define a novel gene family. J Biol Chem 1995;270:28824-28832.

  16. Panmartier E, Cabon F, Braun C, D’Urso D, Muller HW, Zale B. Peripheral myelin protein-22 is expressed in rat and mouse brain and spinal cord motoneurons. Eur J Neurosci 1995;7(5):1080-1088.

  17. Carenini S, Neuberg D, Schachner M, Suter U, Martini RE. Localization and functional roles of PMP-22 in peripheral nerves of PO deficient mice. Glia 1999;28:256-264.

  18. Berciano J, Cambarros O, Calleja J, Polo JM, Leno C. The application of nerve conduction and clinical studies to genetic counseling in hereditary motor and sensory neuropathy type I. Muscle Nerve 1989;12:302-306.

  19. Bouche P, Gherardi R, Cathala HP, Lhermitte F, Castaigne P. Peroneal muscular atrophy: Part I. Clinical and electrophisiological study. J Neurol Sci 1983;61:389-399.

  20. Boerkoel CF, Takashima H, Lupski JR. The genetic convergence of Charcot-Marie-tooth disease type 1, 2 and the role of genetics in sporadic neuropathy (review). Curr Neurol Neurosci Rep 2002;2:70-77.

  21. Sander S, Ouvrier RA, McLeod JG, Nicholson GA, Pollard JD. Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J Neurol Neurosurg Psychiatry 2000;68:483-488.

  22. Miller CC, Ackerley S, Brownlees J, Grierson AJ, Jacobsen NJ, Thornhill P. Axonal transport of neurofilaments in normal and disease states. Cell Mol Life 2002;59:323-30.

  23. Krajewski KM, Lewis RA, Fuerst DR, et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type IA. Brain 2000;123:1516-1527.

  24. Birouk, Gouider R, Le Guern E, Gugeheim M, Tardieu S, Maisonobe T. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 1997;120:813-823.

  25. Dick PJ, Lais AC, Offord KP. The nature of myelinated nerve fiber degeneration of myelinated inherited hypertrophic neuropathy. Mayo Clin Proc 1974;49:39-59.

  26. Lewis RA, Summer AJ. The electrodiagnostic distribution between chronic familial and acquired demyelinative neuropathies. Neurology 1982;32:592-596.

  27. Dashiell SM, Tanner SL, Pant HC, Quarles RH. Myelin-associated glycoprotein modulates expression and phosphorylation of neural cytoskeletal elements and their associated kinases. J Neurochem 2002;81:12663-1272.

  28. Hammersen F, Gidlöf A, Larsson J, Lewis DH. The occurrence of paracrystalline mitochondrial inclusions in normal human skeletal muscle. Acta Neuropathol 1980;49:35-41.

  29. Ghadially FN. Mitochondria: In: Ghadially FN, et al. editors. Ultrastructural pathology of the cell. London: Butterwords; 1975. p. 101-185.




2020     |     www.medigraphic.com